Credo Therapies Ltd
The Centre for Research on Eating Disorders at Oxford (CREDO) has been a pioneer in the development and evaluation of treatments for eating disorders since 1981. Funded by the Wellcome Trust, CREDO focuses on innovative therapeutic approaches and research to improve treatment outcomes for individuals with eating disorders.
Founded: 25 Oct 2022
Industries:
86900 - Other human health activities
Website: credo-oxford.com
Location: Oxford
Products & Services
• cbt
• clinical impairment assessment questionnaire (cia)
• clinical research
• cognitive behavioural self-help for eating disorders
• cognitive behaviour therapy for bulimia nervosa (cbt-bn)
• direct-to-user form of cbt-e delivered via the internet (cbte)
• eating disorder examination interview (ede)
• eating disorder examination questionnaire (ede-q)
• eating disorders
• interpersonal psychotherapy for bulimia nervosa (ipt-bn)
• psychotherapy
• therapy
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
5
Shareholders
14
Controllers (PSC)
3
Bruce Malcolm Gordon
Director • British • Lives in England • Born in Nov 1959
Rebecca Anne Murphy
Director • British • Lives in England • Born in Oct 1976
Lingyun Shao
Director • American • Lives in United States • Born in Aug 1977
Joel Schoppig
Director • Swiss • Lives in United Kingdom • Born in Aug 1985
Nicholas Joseph Mercadante
Director • American • Lives in United States • Born in Aug 1981
Basic Information
LTD
25 Oct 2022
ENGLAND WALES
Yes
Industry Classification
86900
Company Attributes
N/A
N/A
N/A
N/A
Summary
8
Officers
3
PSCs
0
Filings